Skip to main content

Table 7 Comparative outcomes of present study with previously published pediatric CRRT studies; FO, fluid overload, EM electrolyte management

From: Pediatric continuous renal replacement therapy: have practice changes changed outcomes? A large single-center ten-year retrospective evaluation

 

Our Study

ppCRRT Registry a, b

Spain c, d

Birmingham e

Alberta (CRRT only) f

N

273

344

174

76

49

Weight

 Mean/Median Wt (kg)

33.5

34.3

 

19.5(2.5–150)

19.5 (5.5–45)

 Less than 10 kg (%)

23

24

43

  

 10 to 20 kg (%)

25

20

   

 20 to 50 kg (%)

25

29

   

 > 50 kg (%)

27

27

   

Age

 Mean / Median Age (yr)

8.4

8.5

4.3 (±5.3)

5.8 (0–17.8)

5.4 (0.3–13.8)

 0 to 1 yr. (%)

21

20

43.7

  

 1 to 3 yr. (%)

12

13

   

 3 to 5 yr. (%)

8

8

   

 5 to 10 yr. (%)

14

17

   

 10 to 15 yr. (%)

21

19

   

 15 to 21 yr. (%)

20

20

   

 > 21 yr. (%)

4

3

   

Survival to discharge (%)

48

58

64

55

67

Principle diagnosis (%)

 Sepsis

5

24

20

12

 

 BMT

12

16

 

16

 

 Cardiac

9

12

56

9

 

 Renal

10

9

10

20

 

 Liver

21

8

 

6

 

 Malignancy

13

8

 

8

 

 Ischemia/shock

 

6

   

 Inborn error of metabolism

5

4

7

  

 Drug intoxication

 

4

2

  

 Tumor lysis syndrome

 

3

3

14

 

 Pulmonary

5

3

   

 Other

11

2

05

14

 

Survival on CRRT by Weight (N (%))

 < 10 kg

28 (43%)

36 (43%)

57%

  

 > 10 kg

105 (49%)

165 (63%)

73%

  

ICU days before CRRT

4 (1,10)

2

  

2 (1–5)

Days on CRRT

8 (4,16)

   

7 (3–18)

% FO

15 (8, 26)

  

12.9 (0–66.4)

20.1 (5.4–32.5)

Indication for CRRT & survival (%)

 FO and EM

29 (41%)

15

32g

  

 FO

67 (45%)

18

   

 EM

8(50%)

20

42h

  

 Prevent FO /provide nutrition

5(56%)

20

   

 Other

24 (55%)

21

   
  1. a. Symons JM, Chua AN, Somers MJ, et al. Demographic characteristics of pediatric continuous renal replacement therapy: a report of the prospective pediatric continuous renal replacement therapy registry. Clin J Am Soc Nephrol. July 2007;2(4):732–738
  2. b. Sutherland SM, Zappitelli M, Alexander SR, et al. Fluid overload and mortality in children receiving continuous renal replacement therapy: the prospective pediatric continuous renal replacement therapy registry. Am J Kidney Dis. Feb 2010;55(2):316–25
  3. c. Lopez-Herc J, Santiago MJ, Solana MJ et al. Clinical course of children requiring prolonged continuous renal replacement therapy. Pediatr Nephrol. Dec 2010; 25:523–528
  4. d. Santiago MJ, Lopez-Herce J, Urbando J, et al. Clinical course and mortality risk factors in critically ill children requiring continuous renal replacement therapy. Intensive Care Med. May 2010;36(5):843–9
  5. e. Hayes LW, Oster RA, Tofil NM, et al. Outcomes of critically ill children requiring continuous renal replacement therapy. J Crit Care. Sep 2009;24(3):394–400
  6. f. Boschee E, Cave D, Garros D, et al. Indications and outcomes in children receiving renal replacement therapy in pediatric intensive care. J Crit Care. Feb 2014;29(1):37–42
  7. g. Patients with diagnosis of AKI and hypervolemia
  8. h. Patients with diagnosis of AKI